NFKB1 and hepatocellular carcinoma: Besides regulating the modification of NEMO, HBeAg protein also can modulate the NF-κB pathway in hepatoma cells via suppressing IL-18 and IL-1β-mediated NF-κB signaling (Wilson et al., 2011; Jegaskanda et al., 2014).